Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

US FDA grants interchangeability designation to Celltrion's denosumab biosimilars, Stoboclo and Osenvelt: Incheon, South Korea Friday, October 31, 2025, 10:00 Hrs [IST] Celltrion, ...

A 75-year-old man, Mr. A, had prostate cancer that had metastasized to his pelvis and spine. Multiple anticancer drugs and ...

The Food and Drug Administration (FDA) has designated Stoboclo ® (denosumab-bmwo) and Osenvelt ® (denosumab-bmwo) as interchangeable biosimilars to the reference products Prolia ® (denosumab) and ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of therapy, 59% achieved PSA50 response and 32% achieved P ...

A healthy diet can turn things around faster than you can imagine. Dr. Dawn Mussallem, who appeared on Mel Robbins’ podcast, ...

Ewing sarcoma is one of the most common types of bone cancer found in children and teenagers. When the cancer spreads to ...